FDA Approved: BARHEMSYS — Original Application (Acacia Pharma Ltd)

View source ↗

Summary

The FDA approved BARHEMSYS (amisulpride) via the Original Application for the prevention of postoperative nausea and vomiting in adults, marking its entry into …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Barhemsys (rolapitant)

Snippet

ORIG AP for BARHEMSYS (AMISULPRIDE)